Mastectomy rates are decreasing in the era of service screening: a population-based study in Italy (1997–2001) by Zorzi, M et al.
Short Communication
Mastectomy rates are decreasing in the era of service screening:
a population-based study in Italy (1997–2001)
M Zorzi
1, D Puliti
2, M Vettorazzi
1, V De Lisi
3, F Falcini
4, M Federico
5, S Ferretti
6, IF Moffa
7, L Mangone
8,
MP Mano
9, C Naldoni
10, A Ponti
11, A Traina
12, R Tumino
13 and E Paci*,2 for the IMPACT Working Group
14
1Istituto Oncologico Veneto, Padova, Italy;
2Clinical and Descriptive Epidemiology Unit-CSPO-Research Institute of the Tuscany Region, Firenze, Italy;
3Parma Cancer Registry, Parma, Italy;
4Romagna Cancer Registry, Forlı`, Italy;
5Modena Cancer Registry, Modena, Italy;
6Ferrara Cancer Registry, Ferrara,
Italy;
7Epidemiology Unit-ASL 2, Perugia, Italy;
8Reggio-Emilia Cancer Registry, Reggio-Emilia, Italy;
9University of Turin-Department of Biological Sciences
and Human Oncology, Turin, Italy;
10Screening program-Emilia-Romagna Region Health Department, Bologna, Italy;
11Epidemiology Unit-CPO Piemonte,
Turin, Italy;
12Department of Oncology-ARNAS Ascoli, Palermo, Italy;
13Cancer Registry and Human Pathology Department-Arezzo Hospital, Ragusa, Italy
We enrolled all 2162 in situ and 21148 invasive cases of breast cancer in 17 areas of Italy, diagnosed in 1997–2001. Rates of early
cancer increased by 13.7% in the screening age group (50–69 years), and breast conserving surgery by 24.6%. Advanced cancer rates
decreased by 19.4%, and mastectomy rates by 24.2%. Service screening did not increase mastectomy rates in the study population.
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In 2001, the authors of the Cochrane review of mammographic
screening published on the Lancet website claimed that screening
is associated with an increase of mastectomy rates (Olsen et al,
2001). In 2002, a study of changes in surgical treatment of breast
cancer in the city of Florence (Paci et al, 2002) concluded that
breast conserving surgery (BCS) was beneficial and showed a
decreasing trend in mastectomy rates. In a subsequent paper
considering the harms and benefits of screening, Gotzsche (2004)
asserted that there would be about 20% more mastectomies when
women are screened than if they are not screened.
The purpose of this paper is to evaluate the changes introduced
by service screening in the use of BCS and mastectomies in the
period 1997–2001. We focused on the appropriateness of the
surgical approach to cases where BCS was recommended in
accordance with the existing guidelines (FONCaM, 2001). We
present the trends of the mastectomy and BCS rates in Italian areas
covered by a population-based registry, with or without a service-
screening programme.
MATERIALS AND METHODS
The study included all breast cancers diagnosed between 1997 and
2001 in women aged 40–79 years who were resident in 17 areas
mainly located in central and northern Italy. The characteristics of
both the breast cancer screening programmes and main perfor-
mance indicators have been described in detail (Giordano et al,
1996).
In all areas, a registry was active at the start of screening.
Cases were included according to the IARC rules for cancer
registration (Zanetti et al, 2002). In situ carcinomas were included,
whereas death certificate only and multiple primaries were
excluded.
All breast cancers were classified by size and nodal status
according to the TNM-UICC classification and on the basis of the
data reported by each local centre (Sobin and Wittekind, 1997).
Breast cancer cases, in situ or invasive, with a size of 30mm or
less were classified as ‘early’. Invasive cancer cases with sizes
greater than 30mm, irrespective of nodal status, were classified as
‘advanced’. Surgical treatment was classified in two categories:
breast conserving surgery (including excisional biopsy, wide local
excision and quadrantectomy) and mastectomy (including all
types of mastectomy).
All registry-based breast cancer cases were linked to the
screening file and divided by detection method. We divided cases
primarily as either screen-detected (SD) or not screen-detected
(NSD). Cases in the NSD division were further divided so that
there were four main case divisions. They were:
SD cases
(1) Having a tumour detected in the first or subsequent round at
the first screening test and cases having a tumour detected at a
repeated screening test.
NSD cases
(2) Diagnosed clinically outside the screening process following a
negative screening test (includes interval cancer cases).
(3) Diagnosed within women who never responded to their
invitation – the never-respondent case division.
(4) Diagnosed before an invitation could be sent (as it took several
years to achieve full coverage of the population with an
invitation to screening) – the not-yet-invited case division.
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comparing the not-yet-invited case division with the combination
of divisions 1, 2 and 3 – all invited women.
Incidence rates of cancer and surgical treatments were
calculated using data on populations by study centre and year
produced by the National Statistics Institute.
The association between independent variables and surgery was
assessed by means of multivariate logistic regression, using the
STATA 7.0 (Stata Corp, 2001) statistical package with a Po0.05
considered statistically significant.
RESULTS
Seventeen areas from six different regions took part in the study.
In total, we enrolled 2162 in situ and 21148 invasive breast cancer
cases incident in the period 1997–2001 (Table 1).
Overall, 61.1% of cases underwent BCS, with an increase during
the study period from 53.8% in 1997 to 65.6% in 2001 (Table 2).
Women aged 70–79 years showed the lowest proportion of BCS
(44.1%) and also the largest proportion of cases without any
surgical therapy (5.9%), whereas no relevant differences were
observed between the younger age classes.
The proportion of BCS was highest for the in situ and invasive
breast cancer cases p10mm, and progressively decreased starting
from cases pT1c (71.5%), with a drop between cases with pT2 p
and 430mm (46.2 and 23.3%, respectively). Only 58.4% pT1micr
received BCS.
Breast conserving surgery was carried out in more than 75% of
SD cases at first test and in 83% of those SD at subsequent tests,
compared to 54.4 and 52.5% in cases not detected by screening –
case divisions not-yet-invited and never-respondent, respectively.
The multivariate logistic odds ratio (OR) of receiving a
mastectomy vs a BCS decreased by 10% per year between 1997
Table 1 Study centres and breast cancer cases included, by regional area
Cases (no.)
Region Centre Screening activation In situ Invasive Total
Emilia Romagna Bologna City June 1997 141 1819 1960
Bologna North November 1997 97 665 762
Cesena December 1997 63 605 668
Ferrara October 1997 109 1462 1571
Forlı ` March 1996 91 635 726
Modena October 1995 319 2281 2600
Parma July 1997 199 1514 1713
Ravenna December 1995 177 1401 1578
Reggio Emilia November 1994 184 1557 1741
Rimini November 1997 60 883 943
Piemonte Torino February 1992 170 1642 1812
Sicilia Palermo — 56 1443 1499
Ragusa February 1994 15 582 597
Toscana Florence City October 1990 109 1467 1576
Florence suburbs May 1992 56 641 697
Umbria Perugia November 1997 87 1041 1128
Veneto Verona July 1999 229 1510 1739
Total 2162 21148 23310
Table 2 Distribution of breast cancer surgical treatment by year of diagnosis and method of detection
Surgical treatment (row %)
Number of cases (%) Conservative Mastectomy Not performed Not reported
Year of diagnosis
1997 4031 17.3 53.8 39.6 3.5 3.1
1998 4402 18.9 58.7 36.3 3.1 1.9
1999 5130 22.0 62.1 33.5 2.5 1.9
2000 5074 21.8 64.0 31.9 2.7 1.5
2001 4673 20.0 65.6 30.1 2.6 1.7
Total 23310 100.0 61.1 34.1 2.8 2.0
Method of detection
All invited 9953 42.7 69.9 26.9 1.8 1.4
SD at first test 3910 16.8 75.7 23.1 0.5 0.7
SD at subsequent tests 1987 8.5 83.0 16.0 0.5 0.6
NSD with a previous test 1647 7.1 65.9 31.1 1.8 1.2
NSD never-respondent 2409 10.3 52.5 39.0 5.2 3.3
Not-yet-invited 13357 57.3 54.5 39.4 3.6 2.5
NSD¼not screen-detected; SD¼screen-detected.
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70–79 years, it was more than double than in women aged 40–49
years (Table 3).
As compared to not-yet-invited cases, the probability of
mastectomy was reduced by more than one-third in SD cases at
first test (OR 0.65, 95% CI 0.58–0.72) and almost halved in those
SD at subsequent tests (OR 0.53, 0.45–0.62), whereas participation
in screening in the past reduced the risk of mastectomy by 12%
(P¼0.09). The OR for mastectomy was significantly lower for
women who were invited to screening than for those who had not
yet been invited (OR 0.77, 95% CI 0.71–0.85), using an intention-
to-treat analysis.
Figure 1 shows the incidence rate trends per 1000 women of BCS
and mastectomies in those aged 50–69 years, the target of service
screening. During the observation period, the proportion of SD
cases (prevalence and incidence tests) in women aged 50–69 years
old increased from 23.4 to 45.8% of the whole incidence rate. Rates
of early breast cancer cases increased by 14.9% as compared to an
increase by 24.6% of BCS rate, whereas the incidence of advanced
cancers decreased by one-fifth (19.4%) with a 24.2% decrease of
mastectomy rates.
The reduction of mastectomy rates was due to a decreased
proportion of mastectomies in early cases (from 31 to 21%,
Po0.001) combined with an increase from 73 to 76% in those
advanced (P¼0.95). Also in the 40–49 years age group, the
proportion of early cancer cases and BCS increased by 13.1 and
20.9%, respectively.
DISCUSSION
In this study, we analysed the impact of the spread of screening
programmes on breast cancer incidence rates and surgical
treatment modality on the whole population in the period 1997–
2001. In the 50–69 years group, the proportion of SD cases
increased.
In all age groups, we observed an increase in incidence rates of
in situ and invasive tumours p30mm and reduction or stability
of larger invasive cases; both these variations were much larger
in women aged 50–69 years invited to participate in service
screening. Overall, the proportion of cases which received BCS
increased by 12% (from 54 to 66%).
The increase of BCS is the combined effect of the increase in
the rates of early tumours, owing to the expected excess of early
breast cancer detected after the invitation to screening, and
the improving appropriateness of BCS. Rates of BCS and early
tumours went in parallel and the appropriateness of surgical
treatment with BCS was especially evident in SD cases and cases
NSD but with a previous screening test. There was also a clear
Table 3 Multivariate logistic analysis of the probability of receiving a
mastectomy by year of diagnosis, age, tumour size and detection method
a
OR
b 95% CI P-value
Year of diagnosis
c
Common OR for a unit increase 0.90 0.88–0.93 o0.001
Age (years)
40–49
d 1.00 — —
50–59 1.15 1.02–1.29 0.018
60–69 1.31 1.16–1.47 o0.001
70–79 2.15 1.93–2.39 o0.001
pT
PTis 0.60 0.53–0.68 o0.001
pT1micr 1.90 1.54–2.35 o0.001
pT1a 0.76 0.64–0.91 0.002
pT1b 0.52 0.47–0.58 o0.001
pT1c
d 1.00 — —
pT1NOS 0.95 0.66–1.38 0.79
pT2 p30mm 2.83 2.61–3.09 o0.001
Method of detection
NSD not yet invited
d 1.00 — —
SD at first test 0.65 0.58–0.72 o0.001
SD at subsequent tests 0.53 0.45–0.62 o0.001
NSD with a previous test 0.88 0.76–1.02 0.09
NSD never respondend 1.19 1.05–1.35 0.007
Log likelihood  10176.3, Po0.0001
CI¼confidence interval; NSD¼not screen-detected; OR¼odds ratio; SD¼screen-
detected. OR and 95% CI.
aExcluded cases with unknown treatment or not operated
and cases with pTX or pTunknown or pT430mm.
bAdjusted by multivariate
regression for each of the variables in the table.
cLinear assumption.
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Figure 1 Women aged 50–69 years: trends of incidence rates (per 1000) of breast cancer cases and surgical interventions*. Proportion of SD cases (first
and subsequent) by year.
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tumours in the population and the decreasing rates of mastec-
tomies.
In all age classes, BCS rates increased by more than 20% and
mastectomy rates decreased by even higher proportions. However,
in women aged 50–69 years, we observed a 24% reduction in
mastectomy rates, notwithstanding the increasing proportion of
mastectomies appropriately carried out in large invasive cases
(from 73 to 76%).
The proportion of cases receiving a mastectomy was directly
associated with increasing tumour size, except for cases with a
micro-invasive component, who underwent mastectomy in more
than 40% of cases, probably because of the in situ multifocal
component which was responsible for the indication of mastectomy.
In the Netherlands, no increase was observed in the use of BCS
for patients 50–69 years of age across a 9-year period (64% both in
1990 and 1998), but proportions were used and not population
incidence rates as in this paper (Ernst et al, 2001). In a recent study
in Australia (Samnakay et al, 2005), of all patients undergoing
surgery for breast cancer within service screening, the 59.5% in the
screen group and 42.3% in the non-screen group had BCS.
Results from this large population-based study in Italy reject the
hypothesis that service screening increases mastectomy rates in the
population. On the contrary, our data confirm that the introduc-
tion of service screening brought about a reduction in mastectomy
rates and improved the appropriateness of treatment of early
tumours with BCS.
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